II. Indications
- Noninvasive Test for Evaluation for advanced fibrosis in Nonalcoholic Fatty Liver Disease
III. Criteria
- BMI: 28 or higher
- Score 1 point
- AST to ALT ration (AAR): 0.8 or higher
- Score 2 points
-
Type 2 Diabetes Mellitus
- Score 1 point
IV. Interpretation
- BARD Score less than 2 has a strong Negative Predictive Value for advanced Hepatic Fibrosis associated with Nonalcoholic Fatty Liver Disease
V. Efficacy (for Total score 2 or higher)
- Test Sensitivity: 89%
- Test Specificity: 44%
- Negative Predictive Value: 90-97%